Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

645 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Recruiting

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

NCT07022223

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Dongyang People's Hospital Dongyang, China
  • Affiliated Hangzhou First People's Hospital Hangzhou, China
  • Zhejiang cancer Hospital Hangzhou, China
View all 18 locations
View Trial Details
Recruiting

Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

NCT06823960

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • AOU SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • IRCCS-AOU di Bologna Bologna, Italy
  • P.O. Garibaldi-Nesima_UOC Ematologia Catania, Italy
  • AO di Cosenza, P.O. "Annunziata" - UOC di Ematologia Cosenza, Italy
View all 15 locations
View Trial Details

Related conditions